STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Dror Ortho-Design, Inc. Launches ZSMILE User Experience Trial

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Dror Ortho-Design (OTC PINK: DROR) has launched a user experience trial for its ZSMILE platform, an AI-based orthodontic solution that straightens teeth using pulsating air delivered by a single custom-made smart aligner. The trial, conducted in Israel, involves eligible patients, orthodontists, and dental professionals. ZSMILE is designed to be used while sleeping or discreetly at home.

The company's first-generation solution received CE mark in 2013 and FDA 510k clearance in 2020, having treated over 250 patients in Israel and Europe. The second-generation ZSMILE includes a mobile app for patients to track progress and a patient management system for doctors, utilizing AI technology for remote monitoring and treatment plan adjustments.

Loading...
Loading translation...

Positive

  • Launched user experience trial for ZSMILE platform, indicating progress towards commercial release
  • First-generation solution received CE mark (2013) and FDA 510k clearance (2020)
  • Successfully treated over 250 patients in Israel and Europe
  • Developed mobile app and patient management system with AI technology for remote monitoring

Negative

  • None.

JERUSALEM, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's smiles by straightening teeth using pulsating air delivered by a single custom-made smart aligner, today announced ahead of the commercial release of the ZSMILE platform, the launch of a user experience trial of its new revolutionary teeth straightening solution that is intended to be used while sleeping or discreetly at home.

ZSMILE Solution

Image 1 - Second generation ZSMILE solution

ZSMILE Platform

Image 2 - ZSMILE works while you sleep

The user experience trial for Dror's new AI-based orthodontic solution will involve a group of eligible patients, as well as orthodontists and dental professionals in Israel. The company's first-generation solution received the European CE mark in 2013 and FDA 510k clearance in 2020, demonstrating that the pulsating air system effectively straightens teeth similarly to traditional aligners. Beyond the clinical trials, this system has successfully treated over 250 patients in Israel and Europe.

Lee Haddad, CEO of Dror, stated, "Our goal with the usability trial of our second-generation solution is to understand how patients and doctors interact with the mobile application, remote monitoring, and patient management system that we developed. Over the past two years, we have designed this system to monitor patient treatment plan compliance in real time, providing essential feedback to both patients and doctors. We aim to make ZSMILE a pain-free, discreet solution that is easy to use and helps doctors scale their practice efficiently. Our mission is to provide millions of people a way to correct their smile without needing to have plastic in their mouth the entire day.”

The ZSMILE app is designed to be a companion for patients, allowing them to track their progress, schedule in-person and remote visits with their doctor, and receive encouraging feedback to remain compliant with their treatment plan. Patients can also use their smartphone's video capability to scan their smile weekly for doctor review. The ZSMILE patient management system is intended to assist doctors by using AI technology to review patient’s scans, monitor progress remotely, modify treatment plans, schedule appointments, and provide access to ZSMILE orthodontic specialists. These specialists would be able to support general dentists and other dental professionals through the ZSMILE process.

About Dror Ortho-Design, Inc.

Dror Ortho-Design, Inc. is an AI-based orthodontic platform company that has developed a proprietary solution to correct people's smiles by straightening teeth using pulsating air delivered by a single custom-made smart aligner. Dror plans to disrupt the aligner market by offering millions of people a revolutionary alternative to traditional aligners. The Company believes that people do not need to change their lifestyle to correct their smile as they are required to do with existing aligner solutions. Rather, we believe that our solution will be able to provide customers with a discreet and hassle-free way to improve their smiles, even while they sleep. The Company’s ZSMILE solution is also intended to provide general practice Dentists as well as Orthodontists a way to grow their practice efficiently by offering a unique and scalable service.

For more information, please visit: www.ZSmile.com

Forward-Looking Statements

Statements made in this news release may be forward-looking statements within the meaning of federal securities laws that are subject to certain risks and uncertainties and involve factors that may cause actual results to differ materially from those projected or suggested. Factors that could cause actual results to differ materially from those in forward-looking statements include, but are not limited to: (i) the ability of Dror to obtain funding; (ii) the ability of Dror to attract and/or maintain manufacturing, research, development and commercialization partners; (iii) the ability of Dror and/or a partner to successfully complete product research and development, including preclinical and clinical studies and commercialization; (iv) the ability of Dror and/or a partner to obtain required governmental approvals; and (v) the ability of Dror and/or a partner to develop and commercialize products prior to, and that can compete favorably with those of, competitors. Additional factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements are contained in Dror's most recent periodic reports that are filed with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10‑K, our Quarterly Reports on Form 10‑Q, and certain Current Reports on Form 8‑K. Dror assumes no obligation to update and supplement forward-looking statements because of subsequent events.

For Investor Inquiries:
Ben Shamsian
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com

SOURCE: Dror Ortho-Design, Inc.

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/01d94bf1-87e3-44da-bbe4-48dd86fb0565
https://www.globenewswire.com/NewsRoom/AttachmentNg/ce318971-7dda-45b8-977f-e19e71a83f8a


FAQ

What is the ZSMILE platform developed by Dror Ortho-Design (DROR)?

ZSMILE is an AI-based orthodontic solution that straightens teeth using pulsating air delivered by a single custom-made smart aligner, designed to be used while sleeping or discreetly at home.

When did Dror Ortho-Design (DROR) launch the user experience trial for ZSMILE?

Dror Ortho-Design launched the user experience trial for ZSMILE on August 5, 2024, ahead of its commercial release.

What regulatory approvals has Dror Ortho-Design (DROR) received for its orthodontic solution?

Dror Ortho-Design's first-generation solution received the European CE mark in 2013 and FDA 510k clearance in 2020.

How many patients has Dror Ortho-Design (DROR) treated with its orthodontic solution?

Dror Ortho-Design has successfully treated over 250 patients in Israel and Europe with its first-generation orthodontic solution.
Dror Ortho-Design

OTC:DROR

DROR Rankings

DROR Latest News

DROR Latest SEC Filings

DROR Stock Data

28.71M
601.46M
28.28%
10%
Personal Services
Consumer Cyclical
Link
Israel
Jerusalem